Skip to main content
TipRanks
Go Ultimate75% OFF

Allergy Therapeutics (HHU) Ratios

1 Followers

Allergy Therapeutics Ratios

DE:HHU's free cash flow for Q4 2026 was £-22.55M. For the 2026 fiscal year, DE:HHU's free cash flow was decreased by £-2.12M and operating cash flow was £-20.43M. See a summary of the company’s cash flow.

Financial ratios
RatiosJun 26Jun 25Jun 24Jun 23Jun 22
Liquidity Ratios
Current Ratio2.291.281.631.812.35
Quick Ratio1.610.761.011.181.72
Cash Ratio1.050.470.630.801.14
Solvency Ratio-0.48-0.38-0.59-0.60-0.27
Operating Cash Flow Ratio-1.39-1.06-1.56-1.67-0.78
Short-Term Operating Cash Flow Coverage-12.31-70.91-53.56-47.71-14.82
Net Current Asset Value£ -44.68M£ -61.06M£ -27.64M£ -31.18M£ 7.21M
Leverage Ratios
Debt-to-Assets Ratio0.770.890.480.540.14
Debt-to-Equity Ratio-6.46-2.138.3517.420.28
Debt-to-Capital Ratio1.181.880.890.950.22
Long-Term Debt-to-Capital Ratio1.212.130.860.930.04
Financial Leverage Ratio-8.41-2.4017.4832.321.93
Debt Service Coverage Ratio-3.29-4.02-7.10-12.15-6.57
Interest Coverage Ratio-5.02-4.31-9.09-14.28-24.03
Debt to Market Cap0.150.140.133.850.00
Interest Debt Per Share0.010.010.010.060.02
Net Debt to EBITDA-1.18-1.61-0.59-0.581.15
Profitability Margins
Gross Profit Margin41.39%45.65%53.87%54.86%67.27%
EBIT Margin-68.45%-61.04%-63.51%-67.91%-17.67%
EBITDA Margin-60.70%-53.46%-55.69%-60.82%-11.94%
Operating Profit Margin-68.45%-53.60%-63.87%-58.49%-17.87%
Pretax Profit Margin-87.55%-73.48%-70.95%-71.53%-18.41%
Net Profit Margin-86.04%-72.91%-72.86%-72.28%-18.93%
Continuous Operations Profit Margin-86.04%-72.91%-72.86%-72.28%-18.93%
Net Income Per EBT98.28%99.23%102.68%101.05%102.83%
EBT Per EBIT127.91%137.08%111.09%122.30%103.05%
Return on Assets (ROA)-59.08%-59.42%-62.04%-64.51%-18.88%
Return on Equity (ROE)496.92%142.35%-1084.28%-2084.75%-36.48%
Return on Capital Employed (ROCE)-63.92%-73.12%-79.62%-72.30%-23.68%
Return on Invested Capital (ROIC)-60.36%-69.33%-75.99%-69.69%-22.74%
Return on Tangible Assets-61.76%-63.41%-66.87%-72.97%-21.34%
Earnings Yield-12.62%-10.59%-22.86%-612.38%-0.10%
Efficiency Ratios
Receivables Turnover4.616.907.068.416.95
Payables Turnover4.556.666.346.585.56
Inventory Turnover2.242.152.002.322.09
Fixed Asset Turnover2.262.272.322.563.60
Asset Turnover0.690.810.850.891.00
Working Capital Turnover Ratio3.215.393.963.032.28
Cash Conversion Cycle162.06167.85176.86145.24161.76
Days of Sales Outstanding79.1652.8651.7343.4252.51
Days of Inventory Outstanding163.15169.79182.69157.33174.88
Days of Payables Outstanding80.2654.8057.5655.5065.63
Operating Cycle242.31222.65234.42200.74227.39
Cash Flow Ratios
Operating Cash Flow Per Share-0.01-0.01-0.01-0.05-0.02
Free Cash Flow Per Share-0.01-0.01-0.01-0.05-0.03
Dividend Paid and CapEx Coverage Ratio-6.52-8.80-9.45-6.62-4.62
Capital Expenditure Coverage Ratio-6.52-8.80-9.45-6.62-4.62
Operating Cash Flow Coverage Ratio-0.48-0.48-1.04-0.86-1.34
Operating Cash Flow to Sales Ratio-0.54-0.52-0.58-0.52-0.19
Free Cash Flow Yield-9.08%-8.44%-20.20%-505.95%-0.13%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-7.89-9.46-4.37-0.16-968.54
Price-to-Sales (P/S) Ratio6.826.883.190.12183.36
Price-to-Book (P/B) Ratio-39.36-13.4447.443.40353.31
Price-to-Free Cash Flow (P/FCF) Ratio-11.01-11.85-4.95-0.20-777.22
Price-to-Operating Cash Flow Ratio-12.70-13.20-5.47-0.23-945.55
Price-to-Earnings Growth (PEG) Ratio-1.100.440.05-0.001.68
Enterprise Value Multiple-12.41-14.48-6.31-0.78-1534.25
Enterprise Value450.81M426.23M194.01M28.18M13.33B
EV to EBITDA-12.41-14.48-6.31-0.78-1534.25
EV to Sales7.537.743.510.47183.22
EV to Free Cash Flow-12.16-13.33-5.46-0.79-776.64
EV to Operating Cash Flow-14.03-14.84-6.04-0.91-944.84
Tangible Book Value Per Share-0.00-0.01-0.00-0.010.05
Shareholders’ Equity Per Share-0.00-0.010.000.000.06
Tax and Other Ratios
Effective Tax Rate0.020.01-0.03-0.03-0.08
Revenue Per Share0.010.010.010.090.11
Net Income Per Share-0.01-0.01-0.01-0.06-0.02
Tax Burden0.980.991.031.011.03
Interest Burden1.281.201.121.051.04
Research & Development to Revenue0.320.280.410.340.22
SG&A to Revenue0.780.700.410.420.29
Stock-Based Compensation to Revenue0.000.020.000.000.01
Income Quality0.620.730.800.721.02

Currency in GBP